Cargando…

The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer

Alteration of metabolism in cancer cells is a central aspect of the mechanisms that sustain aggressive traits. Aldo–keto reductase 1 B1 (AKR1B1) catalyzes the reduction of several aldehydes to alcohols consuming NADPH. Nevertheless, the ability of AKR1B1 to reduce different substrates renders diffic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Benedetto, Carolina, Borini Etichetti, Carla, Cocordano, Nabila, Cantoia, Alejo, Arel Zalazar, Evelyn, Bicciato, Silvio, Menacho-Márquez, Mauricio, Rosano, Germán Leandro, Girardini, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538543/ https://www.ncbi.nlm.nih.gov/pubmed/37780210 http://dx.doi.org/10.3389/fmolb.2023.1145279

Ejemplares similares

Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
por: Borini Etichetti, Carla M, et al.
Publicado: (2020)

Dynamic regulation of Pin1 expression and function during zebrafish development
por: Ibarra, Maria Solange, et al.
Publicado: (2017)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: Anselmino, L. E., et al.
Publicado: (2021)

Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation
por: Wang, Huiwen, et al.
Publicado: (2023)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
por: Zeng, Chen-Ming, et al.
Publicado: (2017)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
por: Arthur, Jonathan W., et al.
Publicado: (2010)

AKR1C2 and AKR1C3 expression in adipose tissue: Association with body fat distribution and regulatory variants
por: Ostinelli, Giada, et al.
Publicado: (2021)

AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Pleiotropic Actions of Aldehyde Reductase (AKR1A)
por: Fujii, Junichi, et al.
Publicado: (2021)

The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
por: Khanim, F, et al.
Publicado: (2014)

The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death
por: Li, Wei, et al.
Publicado: (2016)

The metabolic plasticity of B cells
por: Vivas-García, Yurena, et al.
Publicado: (2022)

CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis
por: Fan, Yu, et al.
Publicado: (2021)

Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
por: Muneer, Iqra, et al.
Publicado: (2021)

New Insight into microRNA Functions in Cancer: Oncogene–microRNA–Tumor Suppressor Gene Network
por: Zhou, Kecheng, et al.
Publicado: (2017)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

Haemopoietic stem cells in leukaemic AKR mice: the (AKR x C57BL/6)F1 mouse as an in vivo assay system.
por: Schwartz, G. N., et al.
Publicado: (1982)

CircularLRRC7 is a Potential Tumor Suppressor Associated With miR-1281 and PDXP Expression in Glioblastoma
por: Kong, Xue, et al.
Publicado: (2021)

Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma
por: Li, Changjiu, et al.
Publicado: (2021)

High-Intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-Derived Oncogenes and Tumor Suppressors
por: Jee, Hyunseok, et al.
Publicado: (2022)

Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death
por: Phoo, Nang Lae Lae, et al.
Publicado: (2021)

AKR1C enzymes sustain therapy resistance in paediatric T-ALL
por: Bortolozzi, Roberta, et al.
Publicado: (2018)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
por: Möller, Gabriele, et al.
Publicado: (2022)

A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia
por: Robles-Valero, Javier, et al.
Publicado: (2017)

Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities
por: Makgoo, Lilian, et al.
Publicado: (2022)

Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo
por: Nikolaou, Nikolaos, et al.
Publicado: (2020)

Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue
por: Oakley, Julia, et al.
Publicado: (2023)

Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses
Publicado: (1981)

LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
por: Ribeiro, Marcelle C., et al.
Publicado: (2018)

AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells
por: Zhao, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fg74b9gus0g3hlj8p7akhvrgps